BCM
MNTA

Beryl Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Beryl Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,154,930
Closed -$60.6M – 271
2020
Q3 		$60.6M Buy
+1,154,930
New +$47.8M 10.91% 2

Beryl Capital Management's MNTA Position: Q4 2020 in Review

Beryl Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,154,930 shares — an estimated $60.6M sold.

Beryl Capital Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $60.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Beryl Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Beryl Capital Management sold 1,154,930 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $60.6M.
  • Beryl Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Beryl Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $60.6M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Beryl Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.